Estradiol/Levonorgestrel (Transdermal)

By /

Estradiol/Levonorgestrel (Transdermal)

Uses & Indications

Estradiol/levonorgestrel transdermal patch is a combination hormone replacement therapy (HRT) primarily prescribed to women who have reached menopause or experience estrogen deficiency due to ovarian failure or surgical removal of ovaries. This treatment addresses a range of symptoms associated with low estrogen and progesterone levels, including:

  • Moderate to severe vasomotor symptoms such as hot flashes and night sweats
  • Urogenital atrophy symptoms including vaginal dryness, itching, and painful intercourse
  • Prevention of osteoporosis in postmenopausal women at high risk of fractures who cannot use other treatments
  • Regulation of menstrual cycles in cases of hormone imbalance, such as irregular or absent periods
  • Relief from mood disturbances associated with menopause

The patch provides an alternative to oral hormone therapy by delivering hormones transdermally, avoiding gastrointestinal metabolism and providing steadier hormone levels.

How It Works

This transdermal patch delivers two hormones through the skin into systemic circulation:

  1. Estradiol: The primary natural estrogen hormone in women, estradiol binds to estrogen receptors found in many tissues, including the brain, bones, skin, and the reproductive tract. Its functions include:
    • Regulating the menstrual cycle by acting on the hypothalamic-pituitary-ovarian axis
    • Maintaining vaginal and urethral tissue health by promoting lubrication and elasticity
    • Supporting bone density by inhibiting osteoclast activity and promoting bone formation
    • Influencing lipid metabolism and cardiovascular function
    • Modulating mood and cognitive function via central nervous system receptors
  2. Levonorgestrel: A synthetic progestin that mimics the actions of natural progesterone. It balances the effects of estradiol by:
    • Preventing endometrial hyperplasia, which can increase the risk of uterine cancer when estrogen is given alone
    • Regulating the menstrual cycle and promoting regular withdrawal bleeding
    • Exhibiting contraceptive effects by thickening cervical mucus and altering endometrial lining (in contraceptive doses)

Delivering these hormones through the skin bypasses the liver’s first-pass metabolism, reducing the production of clotting factors and triglycerides, which are associated with oral estrogens’ increased risk of thromboembolism. This method results in more stable plasma hormone levels and may reduce side effects such as nausea and headaches.

Dosage and Administration

The dosing regimen for the estradiol/levonorgestrel transdermal patch varies depending on the brand and patient needs, but typical guidance includes:

  • Patch Strengths: Most commonly available in patches delivering 50 mcg estradiol and 0.14 mg levonorgestrel per 24 hours, but variations exist.
  • Application Frequency: Usually one patch applied twice weekly (every 3-4 days).
  • Application Sites: Clean, dry, intact skin on the lower abdomen, buttocks, or upper outer arm. Avoid breasts, irritated, or broken skin.
  • Site Rotation: Rotate application sites with each new patch to minimize local skin irritation.
  • Application Instructions:
    • Wash and dry hands before and after applying the patch.
    • Remove the patch from the protective liner without touching the sticky side.
    • Press firmly to skin for about 10 seconds to ensure adhesion.
    • Avoid using creams, oils, or lotions on the application area before applying the patch.
    • The patch is water-resistant and can be worn during bathing or swimming.
  • Missed Patch: If the patch falls off or is not replaced on schedule, apply a new patch as soon as possible. Use backup contraception if applicable until the patch has been applied for 7 consecutive days.

Patients should be counseled on proper application technique and adherence to dosing schedules to maintain therapeutic effectiveness and reduce side effects.

Side Effects

While estradiol/levonorgestrel patches are generally well tolerated, side effects may occur. These include:

Common Side Effects

  • Skin reactions at the application site such as redness, itching, rash, or irritation
  • Breast tenderness, swelling, or pain
  • Nausea and abdominal discomfort
  • Headaches or migraines
  • Mood changes including irritability, depression, or anxiety
  • Spotting, breakthrough bleeding, or changes in menstrual flow
  • Fluid retention and bloating
  • Weight changes

Serious Side Effects

  • Increased risk of venous thromboembolism (deep vein thrombosis, pulmonary embolism)
  • Cardiovascular events such as stroke or myocardial infarction, especially in smokers or women over 35
  • Hypertension
  • Liver dysfunction or cholestasis
  • Breast cancer risk may be elevated with long-term combined hormone therapy
  • Endometrial hyperplasia or cancer risk if progestin is insufficient or not used in combination with estrogen in women with an intact uterus
  • Gallbladder disease

Patients should report any signs of severe headaches, sudden leg pain or swelling, chest pain, shortness of breath, vision changes, or jaundice immediately to their healthcare provider.

Warnings and Precautions

  • Smoking: Women older than 35 who smoke should not use this therapy due to high cardiovascular risk.
  • Thromboembolic Disorders: Contraindicated in women with history or high risk of thromboembolism.
  • Hormone-sensitive Cancers: Avoid use if history of breast, endometrial, or other estrogen-dependent cancers.
  • Liver Disease: Not recommended in active or severe liver dysfunction.
  • Hypertension: Monitor blood pressure periodically during treatment.
  • Pregnancy: Contraindicated during pregnancy; not a contraceptive in this form unless specifically indicated.
  • Breastfeeding: Caution advised; may affect milk production and pass into breastmilk.
  • Mental Health: Monitor patients with history of depression or mood disorders.
  • Regular Follow-up: Required to assess benefits, risks, and screen for breast and endometrial cancer.

Drug Interactions

  • CYP3A4 Inducers: Drugs such as rifampin, carbamazepine, phenytoin, and St. John’s Wort can reduce hormone levels and efficacy by increasing metabolism.
  • Anticoagulants: Hormones can affect coagulation and may alter response to blood thinners.
  • Other Hormonal Therapies: Concurrent use with other estrogens or progestins requires careful management.
  • Metabolism of Other Drugs: May increase or decrease metabolism of drugs like cyclosporine or lamotrigine.

Always inform healthcare providers of all medications and supplements to avoid adverse interactions.

Clinical Considerations

  • Hormone therapy should be individualized based on patient symptoms, risk factors, and preferences.
  • Lowest effective dose should be used for the shortest duration consistent with treatment goals.
  • Annual breast exams and mammography are recommended during therapy.
  • Bone mineral density may improve with estradiol/levonorgestrel therapy, reducing fracture risk.
  • Cardiovascular risks should be weighed against benefits, particularly in older women or those with risk factors.
  • Use in surgical or immobilized patients may require discontinuation to lower thromboembolism risk.

FAQs

Q1: How long does it take to feel relief from menopausal symptoms?
A: Some women notice improvement in hot flashes and mood within 1-2 weeks, with full benefit often achieved after 4-6 weeks.

Q2: Can this patch be used as birth control?
A: This patch is primarily for hormone replacement, not contraception. Specific contraceptive patches with different hormone doses are used for pregnancy prevention.

Q3: What if the patch falls off?
A: Apply a new patch immediately. If it has been off for more than 24 hours, use backup contraception if applicable.

Q4: Can I swim or shower with the patch on?
A: Yes, the patch is water-resistant and will remain effective during normal bathing or swimming.

Q5: Is hormone therapy safe long term?
A: Long-term therapy requires regular medical supervision to balance benefits and risks, including cancer and cardiovascular risk.

Patient Counseling Points

  • Demonstrate correct patch application and site rotation.
  • Emphasize adherence to dosing schedule.
  • Discuss possible side effects and signs that require medical attention.
  • Advise on lifestyle modifications to reduce cardiovascular risk (smoking cessation, exercise).
  • Encourage routine health screenings.

References

  1. U.S. Food and Drug Administration (FDA) – Estradiol/Levonorgestrel Transdermal Patch Information
    https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/estradiol-levonorgestrel-patch
  2. Mayo Clinic – Hormone Replacement Therapy (HRT) Overview
    https://www.mayoclinic.org/tests-procedures/hormone-replacement-therapy/about/pac-20385100
  3. MedlinePlus – Estradiol and Levonorgestrel (Transdermal)
    https://medlineplus.gov/druginfo/meds/a604010.html

Table of Contents

→ Index
Scroll to Top